Corrigendum to "A functional variant in the RAD51 3' UTR is associated with survival of hepatocellular carcinoma patients" [Gene 851 (2022) 146964]

Affiliations

• ¹ Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ² Department of Experimental Research,Guangxi Medical University Cancer Hospital, Nanning 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning 530021, China.
• ³ Drug Clinical Trial Institution, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ⁴ Department of Research Service, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ⁵ Department of Tumor Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ⁶ Department of Experimental Research,Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ⁷ Department of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
• ⁸ Department of Experimental Research,Guangxi Medical University Cancer Hospital, Nanning 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning 530021, China. Electronic address: yuhongping@stu.gxmu.edu.cn.